• Je něco špatně v tomto záznamu ?

A Preliminary Characterization of a Novel Recombinant Clostridial Collagenase Blend

I. Leontovyc, T. Koblas, Z. Berkova, K. Bittenglova, A. Leontovyc, M. Benesik, F. Saudek

. 2021 ; 67 (2) : 82-89.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21027981

Clostridial collagenases are essential biotechnological tissue dissociation agents owing to their ability to cleave different types of collagen. Standardization of collagenase-based protocols has been hampered by impurities in products manufactured from Clostridium histolyticum. To enhance the purification process, we produced recombinant collagenase classes G and H, taking advantage of the Escherichia coli expression system. The respective gene sequences were derived from C. histolyticum and modified by addition of a C-terminal polyhistidine tag. Harvested bacteria were lysed and the collagenase protein was affinity purified using a His-tag column. The purity, identity, integrity of the eluted collagenases G and H were determined by SDS electrophoresis and Western blot. The proteolytic activity of the collagenase G and H blend (rColGH) was determined by the standard FALGPA assay. The tissue dissociation activity was verified using a standardized method for isolation of rat pancreatic islets. Biocompatibility of the blend was validated by a standardized viability assay on the isolated islets. Two batches of rColGH were produced and compared to a commercially available collagenase. Based on our results, we conclude that rColGH is a functional and non-toxic novel recombinant collagenase worth further characterization and blend optimization in order to make it a competitive commercial product.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21027981
003      
CZ-PrNML
005      
20211202144949.0
007      
ta
008      
211105s2021 xr d f 000 0|eng||
009      
AR
035    __
$a (PubMed)34624941
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Leontovyč, Ivan $7 xx0239101 $u Laboratory for the Islets of Langerhans, Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    12
$a A Preliminary Characterization of a Novel Recombinant Clostridial Collagenase Blend / $c I. Leontovyc, T. Koblas, Z. Berkova, K. Bittenglova, A. Leontovyc, M. Benesik, F. Saudek
504    __
$a Literatura
520    9_
$a Clostridial collagenases are essential biotechnological tissue dissociation agents owing to their ability to cleave different types of collagen. Standardization of collagenase-based protocols has been hampered by impurities in products manufactured from Clostridium histolyticum. To enhance the purification process, we produced recombinant collagenase classes G and H, taking advantage of the Escherichia coli expression system. The respective gene sequences were derived from C. histolyticum and modified by addition of a C-terminal polyhistidine tag. Harvested bacteria were lysed and the collagenase protein was affinity purified using a His-tag column. The purity, identity, integrity of the eluted collagenases G and H were determined by SDS electrophoresis and Western blot. The proteolytic activity of the collagenase G and H blend (rColGH) was determined by the standard FALGPA assay. The tissue dissociation activity was verified using a standardized method for isolation of rat pancreatic islets. Biocompatibility of the blend was validated by a standardized viability assay on the isolated islets. Two batches of rColGH were produced and compared to a commercially available collagenase. Based on our results, we conclude that rColGH is a functional and non-toxic novel recombinant collagenase worth further characterization and blend optimization in order to make it a competitive commercial product.
650    _2
$a zvířata $7 D000818
650    _2
$a Clostridium $7 D003013
650    12
$a kolagenasy $7 D017364
650    12
$a Langerhansovy ostrůvky $7 D007515
650    _2
$a krysa rodu Rattus $7 D051381
655    _2
$a časopisecké články $7 D016428
700    1_
$a Koblas, Tomáš $7 xx0070806 $u Laboratory for the Islets of Langerhans, Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Berková, Zuzana $7 xx0081890 $u Laboratory for the Islets of Langerhans, Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Bittenglová, Kateřina, $d 1994- $7 xx0266730 $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Biomedicine - Cell Biology and Pathology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Leontovyč, Adrian $7 _AN102455 $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Benešík, Martin $7 xx0247750 $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Saudek, František, $d 1955- $7 nlk20000083698 $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 67, č. 2 (2021), s. 82-89
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34624941 $y Pubmed
856    41
$u https://fb.cuni.cz/file/5950/fb2021a0010.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20211202144944 $b ABA008
999    __
$a ok $b bmc $g 1728651 $s 1148525
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 67 $c 2 $d 82-89 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

    Možnosti archivace